Nephro-Urology Monthly

Published by: Kowsar

Restless Leg Syndrome: A Neglected Diagnosis

Behzad Einollahi 1 and Neda Izadianmehr 2 , *
Authors Information
1 Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2014, 6 (5); e22009
  • Published Online: September 5, 2014
  • Article Type: Review Article
  • Received: July 14, 2014
  • Revised: July 21, 2014
  • Accepted: July 23, 2014
  • DOI: 10.5812/numonthly.22009

To Cite: Einollahi B, Izadianmehr N. Restless Leg Syndrome: A Neglected Diagnosis, Nephro-Urol Mon. 2014 ; 6(5):e22009. doi: 10.5812/numonthly.22009.

Abstract
Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Epidemiology and Risk Factors
3. Pathophysiology
4. Diagnosis
5. Differential Diagnosis
6. Treatment
7. Treatment Efficacy Measures
8. Conclusions
References
  • 1. Novak M, Shapiro CM, Mendelssohn D, Mucsi I. Diagnosis and management of insomnia in dialysis patients. Semin Dial. 2006; 19(1): 25-31[DOI][PubMed]
  • 2. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007; 14(1): 82-99[DOI][PubMed]
  • 3. Walters AS. Co-morbidity, morbidity and mortality in the restless legs syndrome. Sleep Med. 2007; 4(8): 11-47
  • 4. Hanly PJ, Pierratos A, Mucsi I, Novak M. Sleep disorders in end-stage renal disease. wolters kluwer health. 2014;
  • 5. Ekbom KA. Restless legs syndrome. Acta Med Scand. 1945; 158: 122
  • 6. Willis T. The London Practice of Physick, Or The Whole Practical Part of Physick. 1685; : 672
  • 7. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4(2): 101-19[PubMed]
  • 8. Adler CH. Clinical presentation and diagnosis of restless legs syndrome. Medscape Neurol. 2005; 7(1)
  • 9. Wetter TC. Restless legs syndrome: a review for the renal care professionals. EDTNA ERCA J. 2001; 27(1): 42-6[PubMed]
  • 10. Allen RP. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med. 2007; 120(1 Suppl 1)-21[DOI][PubMed]
  • 11. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004; 5(3): 293-9[DOI][PubMed]
  • 12. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004; 164(2): 196-202[DOI][PubMed]
  • 13. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007; 120(1 Suppl 1)[DOI][PubMed]
  • 14. Bastos JP, Sousa RB, Nepomuceno LA, Gutierrez-Adrianzen OA, Bruin PF, Araujo ML, et al. Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift. Rev Assoc Med Bras. 2007; 53(6): 492-6[PubMed]
  • 15. Araujo SM, de Bruin VM, Nepomuceno LA, Maximo ML, Daher Ede F, Correia Ferrer DP, et al. Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated comorbidities. Sleep Med. 2010; 11(8): 785-90[DOI][PubMed]
  • 16. Patrick LR. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev. 2007; 12(2): 101-12[PubMed]
  • 17. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004; 43(4): 663-70[PubMed]
  • 18. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011; 134: 959-68[DOI][PubMed]
  • 19. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004; 5(4): 385-91[DOI][PubMed]
  • 20. Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006; 129: 2017-28[DOI][PubMed]
  • 21. Pereira JC, Jr, Pradella-Hallinan M, Lins Pessoa H. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo). 2010; 65(5): 548-54[DOI][PubMed]
  • 22. Barriere G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I. The restless legs syndrome. Prog Neurobiol. 2005; 77(3): 139-65[DOI][PubMed]
  • 23. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med. 2003; 348(21): 2103-9[DOI][PubMed]
  • 24. Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012; 35(8): 1039-62[DOI][PubMed]
  • 25. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006; 19(5): 487-93[PubMed]
  • 26. Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest. 2009; 135(1): 74-80[DOI][PubMed]
  • 27. Chen HY, Chiang CK, Wang HH, Hung KY, Lee YJ, Peng YS, et al. Cognitive-behavioral therapy for sleep disturbance in patients undergoing peritoneal dialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2008; 52(2): 314-23[DOI][PubMed]
  • 28. Bonnet MH, Arand DL. Treatment of insomnia. Wolters kluwer health. 2014;
  • 29. Tarsy D. Treatment of restless legs syndrome in adults. Wolters Kluwer Health. 2014;
  • 30. Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M. Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev. 2011; (3)[DOI][PubMed]
  • 31. Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG, Medical Advisory Board of the Willis-Ekbom Disease F. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013; 88(9): 977-86[DOI][PubMed]
  • 32. Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology. 2010; 74(23): 1897-904[DOI][PubMed]
  • 33. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am J Kidney Dis. 2004; 43(5): 763-71[PubMed]
  • 34. Cui Y, Wang Y, Liu Z. Acupuncture for restless legs syndrome. Cochrane Database Syst Rev. 2008; (4)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments